CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Soufflé Therapeutics snags $135m to bring trio of drugs to the clinic 

Positive
AI Analysis

Summary

Soufflé Therapeutics secured $135 million in funding to advance three drug candidates targeting FSHD, heart failure, and muscle & metabolic disorders into clinical development.

Importance:6/10
Sentiment:
0.70
Soufflé TherapeuticsFundingFSHDHeart failureClinical development
Related Companies

Read the original article

Published by Pharmaceutical Technology on October 14, 2026 9:46 AM

Read Original